EUVIMEDEUVIMED entdecken
Kohortenstudie

Exploring the Impact of Expanded Hemodialysis with Super-High-Flux Dialyzer on Inflammation and Gene Expression: A Prospective Cohort Study in Prevalent Hemodialysis Patients

Theerachai Thammathiwat, Tantip Arigul, Thidathip Wongsurawat, Piroon Jenjaroenpun, Prapat Suriyaphol, Watchara Pichitsiri, Supinda Sirilak, Noppakao Kongtal, Suri Tangchitthavorngul, Parttarawee Damee, Pajaree Chariyavilaskul, Jira Jongcharoenkamol und 6 weitere

Blood Purification · 10.04.2026 · 1-14

DOI: 10.1159/000551822 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Blood Purification, online erschienen am 10.04.2026. Verfasst von Theerachai Thammathiwat und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand. Hauptthemen laut MEDLINE: Renal Dialysis, Inflammation, Kidney Failure, Chronic, Gene Expression Regulation. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

End-stage kidney disease (ESKD) features chronic inflammation and immune dysregulation. The effects of long-term expanded hemodialysis (HDx) using a super-high-flux (SHF) dialyzer on peripheral blood mononuclear cell (PBMC) transcriptomes and circulating inflammatory markers are unclear.

Methods

In a single-center pilot study, 10 prevalent hemodialysis patients were evaluated at baseline on standard high-flux hemodialysis and after 12 months on high-efficiency HDx delivered with an SHF dialyzer (ELISIO-17Hx; Nipro, Osaka, Japan). PBMC RNA sequencing was performed by Macrogen (Seoul, South Korea). Serum cytokines/chemokines were quantified by bead-based multiplex immunoassay on the Luminex xMAP platform (MILLIPLEX; Merck, Darmstadt, Germany). Differential expression controlled the false-discovery rate; paired tests compared biomarker levels.

Results

Out of 43 genes analyzed, 12 showed significant upregulation. TNF and CCL4 genes were notably altered after 12 months of HDx (adjusted p = 0.037 and p = 0.025). Serum levels of pro-inflammatory markers – TNF-α, CCL4, CCL2, and MMP-9 – significantly declined, while IL-10 increased (p < 0.001). Specific changes included TNF-α (31.5 [29.2–35.2] to 26.9 [23.7–30.9] pg/mL; p = 0.028), CCL4 (32.5 ± 14.1 to 22.7 ± 8.2 pg/mL; p = 0.015), CCL2 (489.6 ± 97.0 to 319.6 ± 103.5 pg/mL; p < 0.001), and MMP-9 (5,241.5 [4,432.3–19,709.3] to 555.6 [202.0–709.3] pg/mL; p = 0.005). IL-10 increased from 2.80 ± 1.86 to 5.15 ± 2.10 pg/mL (p = 0.001). TNF-β showed a nonsignificant change (mean difference −2.4; p = 0.101). Other markers remained unchanged.

Conclusion

ESKD shows PBMC upregulation of TNF and CCL4, whereas 12-month high-efficiency HDx lowers circulating TNF-α, CCL4, CCL2, and MMP-9. This transcriptome-serum discordance highlights immune dysregulation, while HDx appears to attenuate inflammation; the shift toward anti-inflammatory signals suggests potential clinical benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisInflammationKidney Failure, ChronicGene Expression RegulationHumansFemaleMaleProspective StudiesMiddle AgedAgedLeukocytes, MononuclearPilot ProjectsBiomarkersCytokinesTranscriptome

Stichwörter der Autor:innen

End-stage kidney diseaseExpanded hemodialysisInflammationsRNA sequencingSuper-high-flux dialyzer

Substanzen

BiomarkersCytokines

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.
  • Siriraj Genomics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Siriraj Informatics and Data Innovation Center (SiData+), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Nursing, Naresuan University Hospital, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.
  • Clinical Pharmacokinetics and Pharmacogenomics Research Unit, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Zitieren

APA

Thammathiwat, T., Arigul, T., Wongsurawat, T., Jenjaroenpun, P., Suriyaphol, P., Pichitsiri, W., Sirilak, S., Kongtal, N., Tangchitthavorngul, S., Damee, P., Chariyavilaskul, P., Jongcharoenkamol, J., Phanumartwiwath, A., Takkavatakarn, K., Susantitaphong, P., Eiam-Ong, S., Pongcharoen, S., & Tiranathanagul, K. (2026). Exploring the Impact of Expanded Hemodialysis with Super-High-Flux Dialyzer on Inflammation and Gene Expression: A Prospective Cohort Study in Prevalent Hemodialysis Patients. Blood Purification, 1-14. https://doi.org/10.1159/000551822

Vancouver

Thammathiwat T, Arigul T, Wongsurawat T, Jenjaroenpun P, Suriyaphol P, Pichitsiri W, et al. Exploring the Impact of Expanded Hemodialysis with Super-High-Flux Dialyzer on Inflammation and Gene Expression: A Prospective Cohort Study in Prevalent Hemodialysis Patients. Blood Purification. 2026:1-14. doi:10.1159/000551822

BibTeX
@article{Thammathiwat2026,
  author = {Thammathiwat, Theerachai and Arigul, Tantip and Wongsurawat, Thidathip and Jenjaroenpun, Piroon and Suriyaphol, Prapat and Pichitsiri, Watchara and Sirilak, Supinda and Kongtal, Noppakao and Tangchitthavorngul, Suri and Damee, Parttarawee and Chariyavilaskul, Pajaree and Jongcharoenkamol, Jira and Phanumartwiwath, Anuchit and Takkavatakarn, Kullaya and Susantitaphong, Paweena and Eiam-Ong, Somchai and Pongcharoen, Sutatip and Tiranathanagul, Khajohn},
  title = {Exploring the Impact of Expanded Hemodialysis with Super-High-Flux Dialyzer on Inflammation and Gene Expression: A Prospective Cohort Study in Prevalent Hemodialysis Patients},
  journal = {Blood Purification},
  year = {2026},
  pages = {1--14},
  doi = {10.1159/000551822}
}
Kostenlos starten →